Filter
704
Filtered Results: 704
Text search:
Drug
Prevention
and
Information
Programme
of
the
European
Union
Featured
Recommendations
53
New Publications
150
Language
Document type
No document type
419
Studies & Reports
146
Guidelines
65
Manuals
32
Strategic & Response Plan
23
Fact sheets
9
Situation Updates
5
Training Material
4
Resource Platforms
1
Countries / Regions
Western and Central Europe
75
Eastern Europe
29
Global
26
Sierra Leone
18
Myanmar / Burma
16
Ukraine
15
India
12
Zambia
12
Africa
12
Liberia
11
Kenya
11
Uganda
8
Nigeria
7
Bangladesh
7
Malawi
7
Eastern Europe and Central Asia
7
Lesotho
6
Tajikistan
6
Senegal
5
Ethiopia
5
South Africa
5
Latin America and the Carribbean
5
Guinea
4
Ghana
4
Philippines
4
Nepal
4
Tanzania
4
Cambodia
4
Rwanda
4
Namibia
4
Eswatini/ Swaziland
4
Middle East and North Africa
4
Asia
4
Russia
4
Thailand
3
Botswana
3
West and Central Africa
3
Albania
3
Laos
3
Moldova
3
Georgia
3
Burkina Faso
2
Zimbabwe
2
South Sudan
2
Germany
2
North Macedonia
2
East and Southern Africa
2
Vietnam
2
Congo, Democratic Republic of
1
USA
1
Somalia
1
Pakistan
1
Iraq
1
Afghanistan
1
Turkey
1
Syria
1
Indonesia
1
Ireland
1
Sudan
1
Benin
1
Brazil
1
Serbia
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Poland
1
Armenia
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
173
Clinical Guidelines
57
Public Health
46
Pharmacy & Technologies
19
Key Resources
13
Women & Child Health
10
Capacity Building
5
Toolboxes
HIV
117
TB
117
Mental Health
90
AMR
60
COVID-19
26
Pharmacy
23
Rapid Response
19
Refugee
15
Planetary Health
14
NCDs
14
Ebola
13
Global Health Education
10
Disability
9
Conflict
9
Caregiver
7
NTDs
7
Health Financing Toolbox
7
Polio
3
Natural Hazards
2
Cholera
1
Zika
1
Specific Hazards
1
Social Ethics
1
Health Financing
1
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through ... Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country. These data form part of the data set used to report back to the General Assembly.
Different from the HIV epidemiological estimates that countries produce for data on the state of the epidemic in a country—that is, data for making estimates on the number of people living with HIV, AIDS-related deaths, etc.—GAM collects information on HIV programmes, including the number of people living with HIV who know their HIV status and people on HIV treatment, and on stigma and discrimination. A full list of the indicators is given in the GAM guidelines.
UNAIDS supports countries to collect information on their national HIV responses through ... Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country. These data form part of the data set used to report back to the General Assembly.
Different from the HIV epidemiological estimates that countries produce for data on the state of the epidemic in a country—that is, data for making estimates on the number of people living with HIV, AIDS-related deaths, etc.—GAM collects information on HIV programmes, including the number of people living with HIV who know their HIV status and people on HIV treatment, and on stigma and discrimination. A full list of the indicators is given in the GAM guidelines.
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
... millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women and
children are particularly vulnerable, especially those
in low and middle income countries, where they are
exposed on a daily basis to indoor air pollution from
solid fuels for cooking and heating. In high income
countries, tobacco is the most important risk factor
for chronic respiratory diseases, and in some of
these countries, tobacco use among women and
young people is still increasing.
Constituting the second part of the World Drug Report 2022, ... present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drugs, age and sex, and recent trends in the use of drugs. The chapter also reviews the impact of the coronavirus disease (COVID-19) pandemic on drug use patterns and service provision. Other issues examined in the chapter are the health consequences of drug use, including the number of people in treatment for drug use disorders and the extent of drug injecting and of HIV and hepatitis C among people who inject drugs. The chapter concludes with a review of the extent to which strategies, policies and interventions are in place to respond to the drug use problem.
Healthy maternal nutrition, exclusive breastfeeding, and optimal infant and young child nutrition are critical for appropriate growth and developme...
Scientific advice
Prevention and control of communicable diseases in prison settings.
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and... antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, expressed in mg/kg of estimated biomass, were compared at country and European level. Substantial variations between countries were observed in both sectors. Estimated data on AMC for pigs and poultry were used for the first time. Univariate and multivariate analyses were applied to study associations between AMC and AMR. In 2014, the average AMC was higher in animals (152 mg/kg) than in humans (124 mg/kg), but the opposite applied to the median AMC (67 and 118 mg/kg, respectively). In 18 of 28 countries, AMC was lower in animals than in humans. Univariate analysis showed statistically-significant (p < 0.05) associations between AMC and AMR for fluoroquinolones and Escherichia coli in both sectors, for 3rd- and 4th-generation cephalosporins and E. coli in humans, and tetracyclines and polymyxins and E. coli in animals. In humans, there was a statistically-significant association between AMC and AMR for carbapenems and polymyxins in Klebsiella pneumoniae. Consumption of macrolides in animals was significantly associated with macrolide resistance in Campylobacter coli in animals and humans. Multivariate analyses provided a unique approach to assess the contributions of AMC in humans and animals and AMR in bacteria from animals to AMR in bacteria from humans. Multivariate analyses demonstrated that 3rd- and 4th-generation cephalosporin and fluoroquinolone resistance in E. coli from humans was associated with corresponding AMC in humans, whereas resistance to fluoroquinolones in Salmonella spp. and Campylobacter spp. from humans was related to consumption of fluoroquinolones in animals. These results suggest that from a ‘One-health’ perspective, there is potential in both sectors to further develop prudent use of antimicrobials and thereby reduce AMR.
The ECDC, the EFSA and the EMA have for the f...
This analytical report reviews and discusses the potential role and influence of political commi...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO...
Special Report
This report of the European Centre for Disease Prevention ... Control (ECDC) was coordinated by Teymur Noori. Report review was provided by Andrew J. Amato-Gauci, Anastasia Pharris, Annabelle Gourlay, Amanda Mocroft, Jan C. Semenza, Denis Coulombier and Piotr Kramarz.
Mapping Report - Catalonia (Spain).
Perspectives on drugs
